In a move that might impact major drug makers such as Ranbaxy, Cipla, Cadila Health, and Lupin, the National Pharmaceutical Pricing Authority (NPPA) has capped the prices of 19 medicines and their 43 different drug packs, including anti-infectives, ... Business Standard India, 1 day ago
Pharma firms to be hit as drug regulator caps prices - Rediff.com, 1 day ago
3 images for "cadila health"
PTI [ Updated 16 Sep 2014, 16:07:55 ] New Delhi: Drug firm Zydus Cadila has received a tentative nod from the health regulator USFDA to market Glipizide tablets, used for treatment of diabetes, in America. "Zydus Cadila has received tentative ...India TV, 4 days ago Cadila Health up 3%, diabetic drug gets tentative USFDA nod Money Control, 4 days ago Zydus gets USFDA tentative nod for diabetic tablets Press Trust of India, 4 days ago Zydus gets USFDA tentative nod to market anti-diabetic tablets The Financial Chronicle, 4 days ago
Gilead Sciences Inc. The agreements allow Cadila Healthcare Ltd. (CDH), Cipla Ltd., Hetero Labs Ltd., Mylan Laboratories Ltd. The drug's pricing has drawn criticism from pharmacy benefit managers, as well as questions from U.S. Senators Charles ...BusinessWeek, 5 days ago Drug makers sign pact with Gilead for cheaper Hepatitis-C drug Smart Investor, 4 days ago Gilead inks licensing pacts for Hep C drug with Ranbaxy, Cipla, Mylan, four Indian firms Business Standard India, 3 days ago Gilead (GILD) Slips on Generic Sovaldi Licensing Deals Yahoo! Finance, 3 days ago
More from: Med India, Reuters UK...and 22 other sources
Drug firm Zydus Cadila has received the final approval from the US health regulator to market Potassium Citrate ER tablets used in prevention of kidney stones. Zydus Cadila has received the final approval from the United States Food and Drug Administration ...Business Standard, 1 month ago Zydus Cadila Gets US Regulatory Nod for Kidney Stone Tablets NDTV Profit, 1 month ago Zydus Cadila gets US FDA nod to market kidney stone tablets Livemint.com, 1 month ago Zydus Cadila gets United States Food and Drug Administration nod for kidney stones tablets Economic Times, 1 month ago
Cadila Healthcare Ltd has submitted to BSE a copy of proceedings of the 19th Annual General Meeting of the members of the Company held on July 30, 2014.Source : BSE Read all announcements in Cadila Health To read the full reportMoneycontrol.com, 1 month ago Cadila's Moraiya facility under US FDA lens Business Standard India, 1 month ago USFDA raises a red flag for Cadila's ANDA application Business Standard India, 1 month ago FDA raises concern over drug production process at Cadila Moneycontrol.com, 1 month ago
D On specific stocks, he is betting on pharma stocks and likes Ajanta Pharma , IPCA Labs , Cadila Health , Torrent Pharma and Alembic Pharma . From the FMCG space, he is cautious on cigarette major ITC on the back of tobacco business-related ...Moneycontrol.com, 1 month ago Pharma stocks outperform equity benchmarks, rally 2-14% Moneycontrol.com, 1 month ago
Summary We remain neutral on Cadila Healthcare (CDH) due to lopsided growth, but revise our target price to R1,180 (earlier R910) as we roll our valuations forward to July 2015. We value Cadila using our standard three-stage DCF model with five-year ...Financial Express, 1 month ago Buy SKS Micro, Bharat Forge, Cadila Health: Dharmesh Kant Money Control, 1 month ago Cadila Health up 2.5%, Credit Suisse maintains outperform Money Control, 2 months ago
Zydus Cadila has received the final approval from the USFDA to market Acyclovir tablets in the strenths of 400 mg and 800 mg.Money Control, 1 month ago
Vishal Malkan, malkansview.com advises buying India Cements for a target price of Rs 110 and Adani Enterprises for a target price of Rs 450.Money Control, 1 month ago Buy Hathway Cable, Cadila Health, Wockhardt: AK Prabharkar Money Control, 1 month ago
The barometer index, the S&P BSE Sensex, slipped once again into the red from positive terrain whereas the 50-unit CNX Nifty languished in the negative terrain near the flat line in early afternoon trade. The Sensex was currently down 13.67 points ...Business Standard India, 1 month ago Sun Pharma, Ranbaxy slump Business Standard India, 1 week ago
on your WebpageAdd Widget >Get your members hooked!